BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6293121)

  • 1. Influence of lead and nickel on passive cutaneous anaphylaxis in the rat.
    Laschi A; Tachon P
    Toxicol Lett; 1982 Oct; 13(3-4):185-8. PubMed ID: 6293121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate.
    Goose J; Blair AM
    Immunology; 1969 Jun; 16(6):749-60. PubMed ID: 4306785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mast-cell rosettes in the immunized rat].
    Renoux ML; Wallach D
    C R Seances Soc Biol Fil; 1976; 170(2):318-24. PubMed ID: 183872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lead acetate on hypersensitivity. Experimental study.
    Laschi-Loquerie A; Descotes J; Tachon P; Evreux JC
    J Immunopharmacol; 1984; 6(1-2):87-93. PubMed ID: 6470497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-allergic actions of rottlerin from Mallotus philippinensis in experimental mast cell-mediated anaphylactic models.
    Chan TK; Ng DS; Cheng C; Guan SP; Koh HM; Wong WS
    Phytomedicine; 2013 Jul; 20(10):853-60. PubMed ID: 23632085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate inhibition by oral l-ephedrine of passive cutaneous anaphylaxis of rats: indirect inhibition of anaphylactic chemical mediator release from the mast cell.
    Shibata H; Minami E; Hirata R; Mizutani N; Nabe T; Kohno S
    Inflamm Res; 2000 Oct; 49(10):553-9. PubMed ID: 11089909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins as modulators of the inflammatory response in the rat.
    Tolone G; Bonasera L; Brai M; Tolone C
    G Batteriol Virol Immunol; 1976; 69(7-12):169-74. PubMed ID: 1028639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [1,4]Benzoxazine-2,3-diones as antiallergic agents.
    Loev B; Jones H; Brown RE; Huang FC; Khandwala A; Leibowitz MJ; Sonnino-Goldman P
    J Med Chem; 1985 Jan; 28(1):24-7. PubMed ID: 2578192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive paw anaphylaxis in the rat. Optimum conditions for use in studies on immediate hypersensitivity.
    Baldo BA; Thomas PG; Nelson CL; Taylor KM
    Allergy; 1980 Jul; 35(5):399-408. PubMed ID: 6255814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of passive cutaneous anaphylaxis by pertussis toxin, an islet-activating protein, as a result of inhibition of histamine release from mast cells.
    Nakamura T; Ui M
    Biochem Pharmacol; 1983 Nov; 32(22):3435-41. PubMed ID: 6140011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.
    Inagaki N; Miura T; Nagai H; Koda A
    Jpn J Pharmacol; 1988 Feb; 46(2):189-92. PubMed ID: 3379829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies with the potentiated reagin response to egg albumin.
    Smith SR; Petillo J; Hwang A
    Int Arch Allergy Appl Immunol; 1972; 43(1):145-57. PubMed ID: 4120033
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis.
    Li GZ; Chai OH; Song CH
    Exp Mol Med; 2005 Aug; 37(4):290-6. PubMed ID: 16155406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Anemarrhena asphodeloides on IgE-mediated passive cutaneous anaphylaxis, compound 48/80-induced systemic anaphylaxis and mast cell activation.
    Chai OH; Shon DH; Han EH; Kim HT; Song CH
    Exp Toxicol Pathol; 2013 May; 65(4):419-26. PubMed ID: 22261360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti‑allergic action of bacillus Calmette‑Guerin extract in experimental mast cell‑mediated anaphylactic models.
    Sun M; Wang Y; Zhao H; Yao W; Yu X
    Mol Med Rep; 2017 Nov; 16(5):6248-6254. PubMed ID: 28901381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reaginic type of antibody stimulated by extracts of Bordetella pertussis in inbred strains of mice.
    Clausen CR; Munoz J; Bergman RK
    J Immunol; 1970 Feb; 104(2):312-9. PubMed ID: 4312873
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaphylaxis in Bordetella pertussis-treated mice. III. Passive cutaneous anaphylaxis.
    MUNOZ J; ANACKER RL
    J Immunol; 1959 Dec; 83():640-4. PubMed ID: 14425264
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.
    Tan JW; Israf DA; Harith HH; Md Hashim NF; Ng CH; Shaari K; Tham CL
    Toxicol Appl Pharmacol; 2017 Mar; 319():47-58. PubMed ID: 28167223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.
    Orr TS; Gwilliam J; Cox JS
    Immunology; 1970 Sep; 19(3):469-79. PubMed ID: 5471831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.